• Western blot analysis of extracts of various cell lines, using MR1 antibody (STJ110354) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% non-fat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.
  • Immunofluorescence analysis of PC-12 cells using MR1 Rabbit polyclonal antibody (STJ110354) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.
  • Immunofluorescence analysis of NIH/3T3 cells using MR1 rabbit polyclonal antibody (STJ110354) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.
  • Immunofluorescence analysis of NIH/3T3 cells using MR1 Rabbit polyclonal antibody (STJ110354) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.
  • Immunofluorescence analysis of PC-12 cells using MR1 rabbit polyclonal antibody (STJ110354) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.
  • Western blot analysis of extracts of various cell lines, using MR1 antibody (STJ110354) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.

Anti-MR1 antibody (23-291) (STJ110354)

SKU:
STJ110354

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB/IF
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-MR1 (23-291) is suitable for use in Western Blot and Immunofluorescence research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.05% Proclin300, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:1000-1:5000
IF/ICC 1:50-1:200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MR1
Gene ID: 3140
Uniprot ID: HMR1_HUMAN
Immunogen Region: 23-291
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 23-291 of human MR1 (NP_001522.1).
Immunogen Sequence: RTHSLRYFRLGVSDPIHGVP EFISVGYVDSHPITTYDSVT RQKEPRAPWMAENLAPDHWE RYTQLLRGWQQMFKVELKRL QRHYNHSGSHTYQRMIGCEL LEDGSTTGFLQYAYDGQDFL IFNKDTLSWLAVDNVAHTIK QAWEANQHELLYQKNWLEEE CIAWLKRFLEYGKDTLQRTE PPLVRVNRKETFPGVTALFC KAHGFYPPEIYMTWMKNGEE IVQEIDYGDILPSGDGTYQ
Tissue Specificity Ubiquitous. Low expression is detected in peripheral blood B cells, T cells, monocytes and in bronchial epithelial cells (at protein level). Expressed in plasmablasts or plasma B cells in the lamina propria of ileum, appendix and colon (at protein level). Highly expressed on a subset of CD45-positive CD3-positive thymocytes (at protein level).
Post Translational Modifications N-glycosylated.
Function Antigen-presenting molecule specialized in displaying microbial pyrimidine-based metabolites to alpha-beta T cell receptors (TCR) on innate-type mucosal-associated invariant T (MAIT) cells. In complex with B2M preferentially presents riboflavin-derived metabolites to semi-invariant TRAV1-2 TCRs on MAIT cells, guiding immune surveillance of the microbial metabolome at mucosal epithelial barriers. Signature pyrimidine-based microbial antigens are generated via non-enzymatic condensation of metabolite intermediates of the riboflavin pathway with by-products arising from other metabolic pathways such as glycolysis. Typical potent antigenic metabolites are 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU) and 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU), products of condensation of 5-amino-6-D-ribityaminouracil (5-A-RU) with glyoxal or methylglyoxal by-products, respectively. May present microbial antigens to various TRAV1-2-negative MAIT cell subsets, providing for unique recognition of diverse microbes, including pathogens that do not synthesize riboflavin. Upon antigen recognition, elicits rapid innate-type MAIT cell activation to eliminate pathogenic microbes by directly killing infected cells. During T cell development, drives thymic selection and post-thymic terminal differentiation of MAIT cells in a process dependent on commensal microflora. Acts as an immune sensor of cancer cell metabolome. May present a tumor-specific or -associated metabolite essential for cancer cell survival to a pan-cancer TCR consisting of TRAV38.2-DV8*TRAJ31 alpha chain paired with a TRBV25.1*TRBJ2.3 beta chain on a non-MAIT CD8-positive T cell clone (MC.7.G5), triggering T cell-mediated killing of a wide range of cancer cell types.
Protein Name Major Histocompatibility Complex Class I-Related Gene Protein
Mhc Class I-Related Gene Protein
Class I Histocompatibility Antigen-Like Protein
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Endoplasmic Reticulum Membrane
Golgi Apparatus Membrane
Early Endosome Membrane
Late Endosome Membrane
In The Absence Of Antigen Remains Within The Endoplasmic Reticulum Where It Acts As A Metabolite Sensor
Antigen Binding Triggers Trafficking Of The Ternary Complex To The Plasma Membrane
After Presentation
Most Of These Complexes Are Rapidly Internalized And Degraded Via Endocytosis
A Small Subset Recycles Via Endosomes Back To The Plasma Membrane And May Thus Acquire And Present New Antigens That Do Not Efficiently Reach The Endoplasmic Reticulum
Isoform 1: Cell Membrane
Single-Pass Membrane Protein
Isoform 3: Cell Membrane
The Larger Proportion Remains In The Er In An Immature State
The Subset That Reach Cell Surface Does It Through A B2m-Independent Pathway
Isoform 4: Secreted
Alternative Antibody Names Anti-Major Histocompatibility Complex Class I-Related Gene Protein antibody
Anti-Mhc Class I-Related Gene Protein antibody
Anti-Class I Histocompatibility Antigen-Like Protein antibody
Anti-MR1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance